↓ Skip to main content

Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, October 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)

Mentioned by

twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study
Published in
Journal of Pharmaceutical Policy and Practice, October 2014
DOI 10.1186/2052-3211-7-14
Pubmed ID
Authors

Evans L Sagwa, Aukje K Mantel-Teeuwisse, Nunurai C Ruswa

Abstract

To determine the incidence of symptomatic moderate-to-severe adverse events during treatment of drug-resistant tuberculosis, and to compare their risk and outcomes by patients' human immunodeficiency virus (HIV) co-infection status.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 1%
Unknown 70 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 27%
Researcher 9 13%
Student > Ph. D. Student 8 11%
Other 4 6%
Student > Doctoral Student 4 6%
Other 12 17%
Unknown 15 21%
Readers by discipline Count As %
Medicine and Dentistry 25 35%
Nursing and Health Professions 8 11%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Psychology 4 6%
Social Sciences 3 4%
Other 8 11%
Unknown 19 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2015.
All research outputs
#2,225,068
of 5,032,982 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#45
of 76 outputs
Outputs of similar age
#57,566
of 144,684 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#6
of 6 outputs
Altmetric has tracked 5,032,982 research outputs across all sources so far. This one has received more attention than most of these and is in the 54th percentile.
So far Altmetric has tracked 76 research outputs from this source. They receive a mean Attention Score of 4.5. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,684 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.